O	O	0	12	Coexpression	Coexpression	B-NP	NN	O	0	ROOT	O
O	O	13	15	of	of	B-PP	IN	O	1	NMOD	O
O	O	16	18	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	18	19	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
O	O	19	24	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	25	26	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	26	27	/	/	O	SYM	O	12	P	O
O	O	27	30	Rel	Rel	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	31	34	and	and	O	CC	O	10	NMOD	O
T1	B-Protein	35	38	Sp1	Sp1	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	39	52	transcription	transcription	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	53	60	factors	factor	I-NP	NNS	I-protein	2	PMOD	I-protein
O	O	61	63	in	in	B-PP	IN	O	1	NMOD	O
O	O	64	69	human	human	B-NP	JJ	O	16	NMOD	O
O	O	70	86	immunodeficiency	immunodeficiency	I-NP	NN	O	16	NMOD	O
O	O	87	92	virus	virus	I-NP	NN	O	22	NMOD	O
O	O	93	94	1	1	I-NP	CD	O	16	NMOD	O
O	O	94	95	-	-	O	HYPH	O	16	P	O
O	O	95	102	induced	induce	B-VP	VBN	O	16	NMOD	O
O	O	102	103	,	,	O	,	O	22	P	O
O	O	104	113	dendritic	dendritic	B-NP	JJ	B-cell_type	22	NMOD	B-cell_type
O	O	114	118	cell	cell	I-NP	NN	I-cell_type	27	NMOD	I-cell_type
O	O	118	119	-	-	B-NP	HYPH	O	27	NMOD	O
O	O	119	120	T	T	I-NP	NN	O	27	NMOD	O
O	O	120	121	-	-	I-NP	HYPH	O	27	NMOD	O
O	O	121	125	cell	cell	I-NP	NN	O	27	NMOD	O
O	O	126	134	syncytia	syncytia	I-NP	NN	O	13	PMOD	O
O	O	134	135	.	.	O	.	O	1	P	O

O	O	137	147	Productive	Productive	B-NP	JJ	O	2	NMOD	O
O	O	148	157	infection	infection	I-NP	NN	O	17	SUB	O
O	O	158	160	of	of	B-PP	IN	O	2	NMOD	O
O	O	161	162	T	T	B-NP	NN	B-cell_type	5	NMOD	B-cell_type
O	O	163	168	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	169	173	with	with	B-PP	IN	O	2	NMOD	O
O	O	174	179	human	human	B-NP	JJ	O	9	NMOD	O
O	O	180	196	immunodeficiency	immunodeficiency	I-NP	NN	O	9	NMOD	O
O	O	197	202	virus	virus	I-NP	NN	O	6	PMOD	O
O	O	203	204	1	1	I-NP	CD	O	9	NMOD	O
O	O	205	206	(	(	O	(	O	15	DEP	O
O	O	206	209	HIV	HIV	B-NP	NN	O	15	DEP	O
O	O	209	210	-	-	B-NP	HYPH	O	12	P	O
O	O	210	211	1	1	I-NP	CD	O	12	NMOD	O
O	O	211	212	)	)	O	)	O	9	NMOD	O
O	O	213	222	typically	typically	B-ADVP	RB	O	17	VMOD	O
O	O	223	231	requires	require	B-VP	VBZ	O	0	ROOT	O
O	O	232	236	that	that	B-SBAR	IN	O	17	VMOD	O
O	O	237	240	the	the	B-NP	DT	O	21	NMOD	O
O	O	241	242	T	T	I-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	243	248	cells	cell	I-NP	NNS	I-cell_type	22	SUB	I-cell_type
O	O	249	251	be	be	B-VP	VB	O	18	SBAR	O
O	O	252	262	stimulated	stimulate	I-VP	VBN	O	22	VC	O
O	O	263	267	with	with	B-PP	IN	O	23	VMOD	O
O	O	268	276	antigens	antigen	B-NP	NNS	O	27	NMOD	O
O	O	277	279	or	or	I-NP	CC	O	27	NMOD	O
O	O	280	288	mitogens	mitogen	I-NP	NNS	B-protein	24	PMOD	B-protein
O	O	288	289	.	.	O	.	O	17	P	O

O	O	290	294	This	This	B-NP	DT	O	2	NMOD	O
O	O	295	306	requirement	requirement	I-NP	NN	O	3	SUB	O
O	O	307	310	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	311	315	been	be	I-VP	VBN	O	3	VC	O
O	O	316	326	attributed	attribute	I-VP	VBN	O	4	VC	O
O	O	327	329	to	to	B-PP	TO	O	5	VMOD	O
O	O	330	333	the	the	B-NP	DT	O	8	NMOD	O
O	O	334	344	activation	activation	I-NP	NN	O	6	PMOD	O
O	O	345	347	of	of	B-PP	IN	O	8	NMOD	O
O	O	348	351	the	the	B-NP	DT	O	12	NMOD	O
T10	B-Entity	352	365	transcription	transcription	I-NP	NN	B-protein	12	NMOD	B-protein
T10	I-Entity	366	372	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
T11	I-Entity	373	375	NF	NF	I-NP	NN	B-protein	16	NMOD	B-protein
T11	I-Entity	375	376	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T11	I-Entity	376	381	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T11	I-Entity	382	383	B	B	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	383	384	,	,	O	,	O	16	P	O
O	O	385	390	which	which	B-NP	WDT	O	16	NMOD	O
O	O	391	401	synergizes	synergize	B-VP	VBZ	O	18	SBAR	O
O	O	402	406	with	with	B-PP	IN	O	19	VMOD	O
O	O	407	410	the	the	B-NP	DT	O	25	NMOD	O
O	O	411	423	constitutive	constitutive	I-NP	JJ	B-protein	24	NMOD	B-protein
O	O	424	437	transcription	transcription	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	438	444	factor	factor	I-NP	NN	I-protein	25	NMOD	I-protein
T2	B-Protein	445	448	Sp1	Sp1	I-NP	NN	B-protein	20	PMOD	B-protein
O	O	449	451	to	to	B-VP	TO	O	27	VMOD	O
O	O	452	457	drive	drive	I-VP	VB	O	19	VMOD	O
O	O	458	461	the	the	B-NP	DT	O	32	NMOD	O
T12	B-Entity	462	465	HIV	HIV	I-NP	NN	B-DNA	32	NMOD	B-DNA
T12	I-Entity	465	466	-	-	B-NP	HYPH	I-DNA	32	NMOD	I-DNA
T12	I-Entity	466	467	1	1	I-NP	CD	I-DNA	32	NMOD	I-DNA
T12	I-Entity	468	476	promoter	promoter	I-NP	NN	I-DNA	27	OBJ	I-DNA
O	O	476	477	.	.	O	.	O	3	P	O

O	O	478	486	Recently	Recently	B-ADVP	RB	O	4	VMOD	O
O	O	486	487	,	,	O	,	O	4	P	O
O	O	488	490	we	we	B-NP	PRP	O	4	SUB	O
O	O	491	495	have	have	B-VP	VBP	O	0	ROOT	O
O	O	496	501	found	find	I-VP	VBN	O	4	VC	O
O	O	502	506	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	507	515	vigorous	vigorous	B-NP	JJ	O	8	NMOD	O
O	O	516	527	replication	replication	I-NP	NN	O	13	SUB	O
O	O	528	530	of	of	B-PP	IN	O	8	NMOD	O
O	O	531	534	HIV	HIV	B-NP	NN	O	9	PMOD	O
O	O	534	535	-	-	B-NP	HYPH	O	10	P	O
O	O	535	536	1	1	I-NP	CD	O	10	NMOD	O
O	O	537	542	takes	take	B-VP	VBZ	O	6	SBAR	O
O	O	543	548	place	place	B-NP	NN	O	13	OBJ	O
O	O	549	551	in	in	B-PP	IN	O	13	VMOD	O
O	O	552	564	nonactivated	nonactivated	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	565	571	memory	memory	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	572	573	T	T	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	574	579	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	580	585	after	after	B-PP	IN	O	13	VMOD	O
O	O	586	595	syncytium	syncytium	B-NP	NN	O	22	NMOD	O
O	O	596	605	formation	formation	I-NP	NN	O	20	PMOD	O
O	O	606	610	with	with	B-PP	IN	O	22	NMOD	O
O	O	611	620	dendritic	dendritic	B-NP	JJ	B-cell_type	25	NMOD	B-cell_type
O	O	621	626	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	627	628	(	(	O	(	O	28	DEP	O
O	O	628	631	DCs	DC	B-NP	NNS	B-cell_type	28	DEP	B-cell_type
O	O	631	632	)	)	O	)	O	25	NMOD	O
O	O	632	633	.	.	O	.	O	4	P	O

O	O	634	639	These	These	B-NP	DT	O	3	NMOD	O
O	O	640	648	syncytia	syncytia	I-NP	NN	O	3	NMOD	O
O	O	649	653	lack	lack	I-NP	NN	O	0	ROOT	O
O	O	654	663	activated	activate	B-VP	VBN	O	5	NMOD	O
O	O	664	669	cells	cell	B-NP	NNS	O	3	OBJ	O
O	O	670	672	as	as	B-SBAR	IN	O	3	NMOD	O
O	O	673	683	determined	determine	B-VP	VBN	O	6	SBAR	O
O	O	684	686	by	by	B-PP	IN	O	7	VMOD	O
O	O	687	689	an	an	B-NP	DT	O	10	NMOD	O
O	O	690	697	absence	absence	I-NP	NN	O	8	PMOD	O
O	O	698	700	of	of	B-PP	IN	O	10	NMOD	O
O	O	701	709	staining	staining	B-NP	NN	O	11	PMOD	O
O	O	710	713	for	for	B-PP	IN	O	12	NMOD	O
O	O	714	716	Ki	Ki	B-NP	NN	O	19	NMOD	O
O	O	716	717	-	-	O	HYPH	O	19	NMOD	O
O	O	717	719	67	67	B-NP	CD	O	19	NMOD	O
O	O	720	724	cell	cell	I-NP	NN	O	19	NMOD	O
O	O	725	730	cycle	cycle	I-NP	NN	O	19	NMOD	O
O	O	731	738	antigen	antigen	I-NP	NN	O	13	PMOD	O
O	O	738	739	.	.	O	.	O	3	P	O

O	O	740	743	The	The	B-NP	DT	O	4	NMOD	O
O	O	744	754	expression	expression	I-NP	NN	O	4	NMOD	O
O	O	755	758	and	and	O	CC	O	4	NMOD	O
O	O	759	767	activity	activity	B-NP	NN	O	12	SUB	O
O	O	768	770	of	of	B-PP	IN	O	4	NMOD	O
T13	B-Entity	771	773	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T13	I-Entity	773	774	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T13	I-Entity	774	779	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T13	I-Entity	780	781	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	782	785	and	and	O	CC	O	11	NMOD	O
T3	B-Protein	786	789	Sp1	Sp1	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	790	794	were	be	B-VP	VBD	O	0	ROOT	O
O	O	794	795	,	,	O	,	O	12	P	O
O	O	796	805	therefore	therefore	B-ADVP	RB	O	12	VMOD	O
O	O	805	806	,	,	O	,	O	12	P	O
O	O	807	815	analyzed	analyze	B-VP	VBN	O	12	VC	O
O	O	816	818	in	in	B-PP	IN	O	16	VMOD	O
O	O	819	827	isolated	isolate	B-NP	VBN	O	22	NMOD	O
O	O	828	829	T	T	I-NP	NN	B-cell_type	20	NMOD	B-cell_type
O	O	830	835	cells	cell	I-NP	NNS	I-cell_type	22	NMOD	I-cell_type
O	O	836	839	and	and	O	CC	O	22	NMOD	O
O	O	840	843	DCs	DC	B-NP	NNS	B-cell_type	17	PMOD	B-cell_type
O	O	844	848	from	from	B-PP	IN	O	22	NMOD	O
O	O	849	855	humans	human	B-NP	NNS	O	26	NMOD	O
O	O	856	859	and	and	I-NP	CC	O	26	NMOD	O
O	O	860	864	mice	mouse	I-NP	NNS	O	23	PMOD	O
O	O	864	865	.	.	O	.	O	12	P	O

O	O	866	868	We	We	B-NP	PRP	O	2	SUB	O
O	O	869	873	have	have	B-VP	VBP	O	0	ROOT	O
O	O	874	878	used	use	I-VP	VBN	O	2	VC	O
O	O	879	893	immunolabeling	immunolabeling	B-NP	NN	O	16	NMOD	O
O	O	893	894	,	,	O	,	O	16	P	O
O	O	895	902	Western	Western	B-NP	NN	O	8	NMOD	O
O	O	903	907	blot	blot	I-NP	NN	O	8	NMOD	O
O	O	908	916	analysis	analysis	I-NP	NN	O	16	NMOD	O
O	O	916	917	,	,	O	,	O	16	P	O
O	O	918	921	and	and	O	CC	O	16	NMOD	O
O	O	922	937	electrophoretic	electrophoretic	B-NP	JJ	O	13	NMOD	O
O	O	938	946	mobility	mobility	I-NP	NN	O	13	NMOD	O
O	O	947	952	shift	shift	I-NP	NN	O	16	NMOD	O
O	O	953	956	and	and	I-NP	CC	O	16	NMOD	O
O	O	957	967	supershift	supershift	I-NP	NN	O	16	NMOD	O
O	O	968	974	assays	assay	I-NP	NNS	O	3	OBJ	O
O	O	974	975	.	.	O	.	O	2	P	O

O	O	976	977	T	T	B-NP	NN	B-cell_type	2	NMOD	B-cell_type
O	O	978	983	cells	cell	I-NP	NNS	I-cell_type	3	SUB	I-cell_type
O	O	984	988	lack	lack	B-VP	VBP	O	0	ROOT	O
O	O	989	995	active	active	B-NP	JJ	O	3	OBJ	O
T14	B-Entity	996	998	NF	NF	I-NP	NN	B-protein	8	NMOD	B-protein
T14	I-Entity	998	999	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T14	I-Entity	999	1004	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T14	I-Entity	1005	1006	B	B	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	1007	1010	but	but	O	CC	O	3	VMOD	O
O	O	1011	1018	express	express	B-VP	VBP	O	3	VMOD	O
T4	B-Protein	1019	1022	Sp1	Sp1	B-NP	NN	B-protein	10	OBJ	B-protein
O	O	1023	1025	as	as	B-SBAR	IN	O	10	VMOD	O
O	O	1026	1034	expected	expect	B-VP	VBN	O	12	SBAR	O
O	O	1034	1035	.	.	O	.	O	3	P	O

O	O	1036	1039	DCs	DC	B-NP	NNS	B-cell_type	2	SUB	B-cell_type
O	O	1040	1047	express	express	B-VP	VBP	O	0	ROOT	O
O	O	1048	1052	high	high	B-NP	JJ	O	4	NMOD	O
O	O	1053	1059	levels	level	I-NP	NNS	O	2	OBJ	O
O	O	1060	1062	of	of	B-PP	IN	O	4	NMOD	O
O	O	1063	1066	all	all	B-NP	DT	O	7	NMOD	O
O	O	1067	1072	known	know	I-NP	VBN	O	5	PMOD	O
T15	B-Entity	1073	1075	NF	NF	I-NP	NN	B-protein	11	NMOD	B-protein
T15	I-Entity	1075	1076	-	-	I-NP	HYPH	I-protein	11	NMOD	I-protein
T15	I-Entity	1076	1081	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T15	I-Entity	1082	1083	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	1084	1087	and	and	I-NP	CC	O	14	NMOD	O
T16	B-Entity	1088	1091	Rel	Rel	I-NP	NN	B-protein	14	NMOD	B-protein
T16	I-Entity	1092	1100	proteins	protein	I-NP	NNS	I-protein	7	NMOD	I-protein
O	O	1100	1101	,	,	O	,	O	2	P	O
O	O	1102	1106	with	with	B-PP	IN	O	2	VMOD	O
O	O	1107	1115	activity	activity	B-NP	NN	O	18	SUB	O
O	O	1116	1124	residing	reside	B-VP	VBG	O	16	PMOD	O
O	O	1125	1134	primarily	primarily	B-ADVP	RB	O	20	PMOD	O
O	O	1135	1141	within	within	B-PP	IN	O	18	VMOD	O
T5	B-Protein	1142	1146	RelB	RelB	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	1146	1147	,	,	O	,	O	26	P	O
T6	B-Protein	1148	1151	p50	p50	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	1151	1152	,	,	O	,	O	26	P	O
O	O	1153	1156	and	and	O	CC	O	26	NMOD	O
T7	B-Protein	1157	1160	p65	p65	B-NP	NN	B-protein	20	PMOD	B-protein
O	O	1160	1161	.	.	O	.	O	2	P	O

O	O	1162	1169	However	However	B-ADVP	RB	O	4	VMOD	O
O	O	1169	1170	,	,	O	,	O	4	P	O
O	O	1171	1174	DCs	DC	B-NP	NNS	B-cell_type	4	SUB	B-cell_type
O	O	1175	1179	lack	lack	B-VP	VBP	O	0	ROOT	O
T8	B-Protein	1180	1183	Sp1	Sp1	B-NP	NN	B-protein	4	OBJ	B-protein
O	O	1183	1184	,	,	O	,	O	4	P	O
O	O	1185	1190	which	which	B-NP	WDT	O	4	VMOD	O
O	O	1191	1194	may	may	B-VP	MD	O	7	SBAR	O
O	O	1195	1202	explain	explain	I-VP	VB	O	8	VC	O
O	O	1203	1206	the	the	B-NP	DT	O	11	NMOD	O
O	O	1207	1214	failure	failure	I-NP	NN	O	9	OBJ	O
O	O	1215	1217	of	of	B-PP	IN	O	11	NMOD	O
O	O	1218	1221	HIV	HIV	B-NP	NN	O	12	PMOD	O
O	O	1221	1222	-	-	B-NP	HYPH	O	13	NMOD	O
O	O	1222	1223	1	1	I-NP	CD	O	14	AMOD	O
O	O	1224	1226	to	to	B-VP	TO	O	17	VMOD	O
O	O	1227	1236	replicate	replicate	I-VP	VB	O	15	SBAR	O
O	O	1237	1239	in	in	B-PP	IN	O	17	VMOD	O
O	O	1240	1248	purified	purify	B-NP	VBN	O	20	NMOD	O
O	O	1249	1252	DCs	DC	I-NP	NNS	B-cell_type	18	PMOD	B-cell_type
O	O	1252	1253	.	.	O	.	O	4	P	O

O	O	1254	1266	Coexpression	Coexpression	B-NP	NN	O	9	SUB	O
O	O	1267	1269	of	of	B-PP	IN	O	1	NMOD	O
T17	B-Entity	1270	1272	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T17	I-Entity	1272	1273	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T17	I-Entity	1273	1278	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T17	I-Entity	1279	1280	B	B	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	1281	1284	and	and	O	CC	O	8	NMOD	O
T9	B-Protein	1285	1288	Sp1	Sp1	B-NP	NN	B-protein	2	PMOD	B-protein
O	O	1289	1295	occurs	occur	B-VP	VBZ	O	0	ROOT	O
O	O	1296	1298	in	in	B-PP	IN	O	9	VMOD	O
O	O	1299	1302	the	the	B-NP	DT	O	13	NMOD	O
O	O	1303	1315	heterologous	heterologous	I-NP	JJ	B-cell_type	13	NMOD	B-cell_type
O	O	1316	1318	DC	DC	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	1318	1319	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	1319	1320	T	T	I-NP	NN	O	18	NMOD	O
O	O	1320	1321	-	-	I-NP	HYPH	O	18	NMOD	O
O	O	1321	1325	cell	cell	I-NP	NN	O	18	NMOD	O
O	O	1326	1334	syncytia	syncytia	I-NP	NN	O	10	PMOD	O
O	O	1335	1339	that	that	B-NP	WDT	O	18	NMOD	O
O	O	1340	1343	are	be	B-VP	VBP	O	19	SBAR	O
O	O	1344	1351	induced	induce	I-VP	VBN	O	20	VC	O
O	O	1352	1354	by	by	B-PP	IN	O	21	VMOD	O
O	O	1355	1358	HIV	HIV	B-NP	NN	O	22	PMOD	O
O	O	1358	1359	-	-	B-NP	HYPH	O	23	P	O
O	O	1359	1360	1	1	I-NP	CD	O	23	NMOD	O
O	O	1360	1361	.	.	O	.	O	9	P	O

O	O	1362	1371	Therefore	Therefore	B-ADVP	RB	O	10	VMOD	O
O	O	1371	1372	,	,	O	,	O	10	P	O
O	O	1373	1376	HIV	HIV	B-NP	NN	O	9	NMOD	O
O	O	1376	1377	-	-	B-NP	HYPH	O	3	P	O
O	O	1377	1378	1	1	I-NP	CD	O	3	NMOD	O
O	O	1378	1379	-	-	B-NP	HYPH	O	9	NMOD	O
O	O	1379	1386	induced	induce	I-NP	VBN	O	9	NMOD	O
O	O	1387	1391	cell	cell	I-NP	NN	O	9	NMOD	O
O	O	1392	1398	fusion	fusion	I-NP	NN	O	10	SUB	O
O	O	1399	1405	brings	bring	B-VP	VBZ	O	0	ROOT	O
O	O	1406	1414	together	together	B-ADVP	RB	O	10	VMOD	O
O	O	1415	1422	factors	factor	B-NP	NNS	O	10	OBJ	O
O	O	1423	1427	that	that	B-NP	WDT	O	12	NMOD	O
O	O	1428	1438	upregulate	upregulate	B-VP	VBP	O	13	SBAR	O
O	O	1439	1444	virus	virus	B-NP	NN	O	16	NMOD	O
O	O	1445	1458	transcription	transcription	I-NP	NN	O	14	OBJ	O
O	O	1458	1459	.	.	O	.	O	10	P	O

O	O	1460	1465	Since	Since	B-SBAR	IN	O	17	VMOD	O
O	O	1466	1469	DCs	DC	B-NP	NNS	B-cell_type	6	NMOD	B-cell_type
O	O	1470	1473	and	and	O	CC	O	6	NMOD	O
O	O	1474	1480	memory	memory	B-NP	NN	B-cell_type	6	NMOD	B-cell_type
O	O	1481	1482	T	T	I-NP	NN	I-cell_type	6	NMOD	I-cell_type
O	O	1483	1488	cells	cell	I-NP	NNS	I-cell_type	8	SUB	I-cell_type
O	O	1489	1499	frequently	frequently	B-ADVP	RB	O	8	VMOD	O
O	O	1500	1507	traffic	traffic	B-VP	VBP	O	1	SBAR	O
O	O	1508	1516	together	together	B-ADVP	RB	O	8	VMOD	O
O	O	1517	1519	in	in	B-ADVP	FW	O	8	VMOD	O
O	O	1520	1524	situ	situ	I-ADVP	FW	O	10	AMOD	O
O	O	1524	1525	,	,	O	,	O	17	P	O
O	O	1526	1531	these	these	B-NP	DT	O	14	NMOD	O
O	O	1532	1539	unusual	unusual	I-NP	JJ	O	17	SUB	O
O	O	1540	1552	heterologous	heterologous	I-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	1553	1561	syncytia	syncytia	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	1562	1567	could	could	B-VP	MD	O	0	ROOT	O
O	O	1568	1575	develop	develop	I-VP	VB	O	17	VC	O
O	O	1576	1578	in	in	B-PP	IN	O	18	VMOD	O
O	O	1579	1587	infected	infected	B-NP	JJ	O	21	NMOD	O
O	O	1588	1599	individuals	individual	I-NP	NNS	O	19	PMOD	O
O	O	1600	1603	and	and	O	CC	O	18	VMOD	O
O	O	1604	1608	lead	lead	B-VP	VBP	O	18	VMOD	O
O	O	1609	1611	to	to	B-PP	TO	O	23	VMOD	O
O	O	1612	1619	chronic	chronic	B-NP	JJ	O	26	NMOD	O
O	O	1620	1623	HIV	HIV	I-NP	NN	O	29	NMOD	O
O	O	1623	1624	-	-	B-NP	HYPH	O	29	NMOD	O
O	O	1624	1625	1	1	I-NP	CD	O	29	NMOD	O
O	O	1626	1637	replication	replication	I-NP	NN	O	24	PMOD	O
O	O	1638	1645	without	without	B-PP	IN	O	29	NMOD	O
O	O	1646	1656	ostensible	ostensible	B-NP	JJ	O	33	NMOD	O
O	O	1657	1663	immune	immune	I-NP	JJ	O	33	NMOD	O
O	O	1664	1675	stimulation	stimulation	I-NP	NN	O	30	PMOD	O
O	O	1675	1676	.	.	O	.	O	17	P	O
